Journal of Commercial Biotechnology

Journal of Commercial Biotechnology

Leading thinking on biotechnology business management

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.



Vol 19, Issue 2 (2013)

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Commentary

Capturing Value PDF
G. Steven Burrill
Defining valuable information in a shifting industry PDF
Andrew F Bourgoin
Commercial Biotechnology in Mexico PDF
Minerva Valdes, Fernando Quezada

Articles

Technology Transfer: Bridging academic research and society – a communicative approach PDF
Martin Vad Bennetzen, Lars Stig Møller
The financial ecosystem available to early-stage biotechnology firms and its misalignment with interests of these firms, of the biotechnology industry and with global disease burden PDF
Gergely Toth
A Patient Centric Commercial Model for Cancer Care PDF
Sanjay Rao
Developing Cell Therapies: Enabling cost prediction by value systems modeling to manage developmental risk. PDF
Mark Joseph McCall, David John Williams
Challenges and prospects for monoclonal antibodies in China PDF
Honghao Shi, Meiwan Chen, Yunzhen Shi, Hao Hu, Yitao Wang

From the Boardroom

A Business Perspective on IP: Open Innovation vs. Open Source in Commercializing Biotechnology PDF
Arthur A. Boni
Getting Social with Biotechnology Business Development PDF
Tim McCready

Legal and Regulatory Updates

Bowman v. Monsanto: Revisiting the Exhaustion Doctrine and its Application to Biotechnology and Digital Technologies PDF
Susan Kling Finston
Should the HHS Decision to Overrule FDA on Plan B Be Reversed PDF
Peter J. Pitts


Copyright © thinkBiotech LLC